期刊
EPILEPTIC DISORDERS
卷 23, 期 1, 页码 1-16出版社
JOHN LIBBEY EUROTEXT LTD
DOI: 10.1684/epd.2021.1255
关键词
structural; genetic; infectious; metabolic; immune; neurodegenerative
资金
- Department of Health's NIHR Biomedical Research Centres funding scheme
- Muir Maxwell Trust
- Epilepsy Society
- UCB Pharma
- Sunovion
- Eisai
Identifying the etiology of a patient's epilepsy is crucial for diagnosis, prognostic counseling, and management. Etiologies are categorized into structural, genetic, infectious, metabolic, immune, and neurodegenerative, with genetic factors playing a role in seizure risk for all individuals with epilepsy. These categories are not mutually exclusive, highlighting the importance of etiology in precision medicine and targeted therapies for epilepsy management.
The identification of the aetiology of a patient's epilepsy is instrumental in the diagnosis, prognostic counselling and management of the epilepsies. Indeed, the aetiology can be important for determining the recurrence risk of single seizures and so for making a diagnosis of epilepsy. Here, we divide the aetiologies into six categories: structural, genetic, infectious, metabolic, immune (all of which are part of the International League Against Epilepsy [ILAE] classification system) and neurodegenerative (which we have considered separately because of its growing importance in epilepsy). These are not mutually exclusive categories and many aetiologies fall into more than one category. Indeed, genetic factors probably play a role, to varying degrees, in the risk of seizures in all people with epilepsy. In each of the categories, we discuss what we regard as the most important aetiologies; importance being determined not only by prevalence but also by clinical significance. The introduction contains information suitable for level 1 competency (entry level), whilst the subsequent sections contain information aimed at level 2 competency (proficiency level) as part of the new ILAE competency-based curriculum. As we move towards precision medicine and targeted therapies, so aetiologies will play an even greater role in the management of epilepsy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据